AUG 02, 2018 06:00 AM PDT

Chronic Infections Outsmart the Immune System

Many chronic infections evade the immune system’s defenses so that it can remain comfortably in the host mooching off our bodies. A recent study in Cell Reports looked at how the parasite that causes visceral leishmaniasis, also known as kala-azar or black fever, escapes the host’s defenses. Visceral leishmaniasis, a potentially lethal chronic disease, is the second leading cause of death by parasitic infection. It is caused by the Leishmania species of protozoan parasite and transmitted to humans by the bites of female sandflies. In 2015 the World Health Organization (WHO) reported 300,000 estimated annual cases with over 20,000 deaths each year due to visceral leishmaniasis. Of these cases, 90% were reported to occur in six countries: Bangladesh, Brazil, Ethiopia, India, South Sudan and Sudan. Onset can be chronic or acute, with incubation of weeks to months, and it affects internal organs such as the spleen, liver, and bone marrow.

High power image of nuclei with amastigote forms of Leishmaniasis. Source: Calicut Medical COllege

Interferon-gamma, or type II interferon, is a cytokine essential to innate and adaptive immunity against infections. Interferon-gamma has immunostimulatory and immunomodulatory effects and is produced by natural killer cells in the innate response and T cells CD4 and CD8 during the adaptive immune response. During visceral leishmaniasis, CD4 T cells expressing interferon-gamma appear later in infection and in smaller numbers than expected, but the recent study by Dr. Simona Stager’s team at the Institute National de la Recherche Scientifique (INRS) has shown that the lack of T cells is due to the protective cells dying. To further study this phenomenon they looked at previously identified transcription factors, proteins that modulate the activity of one or more genes, that were present but unusual for CD4 T cells. The specific transcription factor detected, IRF-5, is known for its role in innate immunity but not CD4 T cells.

The study of IRF-5 showed that it leads CD4 cells to self-destruct due to tissue destruction. Previously unknown signals in CD4 cells are activated when tissue is destroyed, causing them to die following a series of reactions that are not fully understood. The mechanism behind this signaling begins with Toll-like Receptor 7 (TLR7), which is usually activated in innate immune cells when a pathogen is recognized. During chronic inflammation cellular residues present after tissue destruction activates TLR7 in CD4 cells. This activation leads to expression of IRF-5, which then increases expression of Death Receptor 5 (DR5) and caspase 8, which leads to cell death. The white blood cells involved in the attack are eliminated by the biological process of the host and not the parasite, allowing the parasite to be protected and sustain a chronic infection.

This mechanism may play a role with other diseases that lead to chronic infection and inflammation. The newly discovered link between chronic inflammation induction of CD4 T cell death by the TLR7 and IRF-5 pathways could lead to new treatment options. A better understanding of this work and the cellular activity induced by IRF-5 in immune cells could reveal new therapeutic targets for visceral leishmaniasis and other chronic inflammatory diseases.

To learn more about leishmaniasis watch the video below!

World Health Organization, Center for Disease Control

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
MAY 16, 2018
Immunology
MAY 16, 2018
Antibodies Neutralize Two Different Hemorrhagic Fever Viruses
Scientists have found evidence for potential antibody-based therapeutics to treat more than one hemorrhagic fever virus at once. From Harvard Medical Schoo...
JUN 06, 2018
Immunology
JUN 06, 2018
Why are women more prone to autoimmunity than men?
For a long time scientists have been trying to understand why females are more likely than males to develop autoimmune diseases. From the University of Got...
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that...
JUL 16, 2018
Immunology
JUL 16, 2018
T cells and the Need for Speed
A recent study has shown that T cell receptors are dispersed across the T cell surface, as opposed to clustered, to allow for a rapid immune reaction....
AUG 06, 2018
Immunology
AUG 06, 2018
Maternal Dengue Immunity Protects Against Infant Zika Infection
Maternal Dengue immunity produces CD8+ T cells that protect against fetal Zika infection preventing zika-related malformations....
AUG 27, 2018
Immunology
AUG 27, 2018
Undiscovered Tunnels from Bone Marrow To Brain
Newly discovered tunnels connect bone marrow of the skull directly to lining of the brain to allow for quick access of immune cells to brain damaged tissues....
Loading Comments...